Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 417 shares, a drop of 67.8% from the August 15th total of 1,295 shares. Based on an average daily volume of 2,661 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are short sold.
Gyrodyne Stock Up 1.4%
GYRO stock traded up $0.07 during trading on Friday, hitting $5.06. 13,130 shares of the company’s stock traded hands, compared to its average volume of 3,040. Gyrodyne has a 52 week low of $4.95 and a 52 week high of $10.90. The stock has a fifty day moving average price of $5.50 and a two-hundred day moving average price of $6.77.
Institutional Investors Weigh In On Gyrodyne
A hedge fund recently bought a new position in Gyrodyne stock. Susquehanna International Group LLP acquired a new stake in Gyrodyne , LLC (NASDAQ:GYRO – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 14,186 shares of the real estate investment trust’s stock, valued at approximately $142,000. Susquehanna International Group LLP owned approximately 0.65% of Gyrodyne at the end of the most recent reporting period. Institutional investors own 71.36% of the company’s stock.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
